MedTrace Logo

Intra-operative Pancreatoscopy in Patients With IPMN

NCT03729453 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-04-20

No results posted yet for this study

Summary

To demonstrate the added value of intraoperative pancreatoscopy in patients undergoing partial pancreatic resection for the treatment of Intraductal Papillary Mucinous Neoplasm (IPMN) as it pertains to detection of discontinuous (skip) lesions in the remnant pancreas; to generate a hypothesis for a subsequent randomized control trial.

Conditions

  • Intraductal Papillary Mucinous Neoplasm

Interventions

DEVICE

SpyGlass

Visualization of main pancreatic duct with SpyGlass catheter.

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Marco Del Chiaro, MD · University of Colorado, Denver

  • G.V. Rao, MD · Asian Institute of Gastroenterology

  • Richard Burkhart, MD · Johns Hopkins University

  • Marc Besselink, MD · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

  • Yi Miao, MD · Nanjing Medical University

  • Sohei Satoi, MD · Kansai Medical University

  • Urban Arnelo, MD · University Hospital, Umeå

  • Christian Schmidt, MD · Indiana University Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-20
Primary Completion
2022-08-11
Completion
2027-05-31
FDA Device
Yes

Countries

  • United States
  • China
  • India
  • Japan
  • Netherlands
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03729453 on ClinicalTrials.gov